Safe Return to Play After ACL Reconstruction
Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Mar 31, 2021
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients ages 15-35 undergoing primary ACL reconstruction
- Exclusion Criteria:
- • patients who are undergoing revision ACL surgery
About Rothman Institute Orthopaedics
Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials